DNA tests have potential to transform next 70 years of NHS care, experts say

July 9, 2018 by Euan Wemyss, University of Aberdeen

Patients in Scotland could benefit from a revolution in personalised healthcare, thanks to major investments in gene sequencing technology.

Researchers say pioneering techniques that can sequence a person's entire genetic make-up in under three days have the potential to transform patient care in the coming decades.

The setting up of two cutting-edge centres for sequencing, in Edinburgh and Glasgow, and the contribution of NHS staff from across Scotland, have laid the foundations that will make the transformation possible.

Work carried out by the Scottish Genomes Partnership, a collaboration led by the Universities of Edinburgh, Glasgow, Aberdeen and Dundee and NHS Scotland, has given researchers unprecedented access to sequencing technologies.

Findings from the project are already helping to improve diagnoses of in the Scottish NHS, as well as advancing the understanding of rare and common diseases including cancer.

More than 400 NHS Scotland patients and their families have now had their entire genetic make-up decoded under the scheme. NHS Scotland Regional Genetics Services have identified sufficient patients with rare inherited conditions to allocate the remainder of the 1,000 genomes available in Scotland as part of the 100,000 Genomes Project.

Professor Tim Aitman, Director of the Centre of Genomic and Experimental Medicine at the University of Edinburgh, is Co-Chair of the Scottish Genomes Partnership.

He said: "As the NHS turns 70, it is the perfect opportunity for the Scottish Genomes Partnership to highlight its hope for the future through the successful between four of Scotland's medical schools, the NHS Scotland Genetics and Laboratory services and Genomics England.

"This technology offers one of the biggest opportunities in today's NHS, delivering precise molecular information that is changing the management of diseases. It could also ultimately enable prevention of diseases. We look forward to working with participants and funders to deliver the next phase of genomic medicine to the people of Scotland."

Professor Andrew Biankin, Director of the Wolfson Wohl Cancer Research Centre at the University of Glasgow and Co-Chair of the Scottish Genomes Partnership, said: "Genomic testing allows us to start predicting which therapies will work best for an individual cancer patient, improving outcomes whilst minimising side-effects and cost. The NHS is optimally positioned to lead in the development and implementation of precision medicine strategies for cancer."

The Scottish Genomes Partnership has received funding from NHS Scotland, the Scottish Government and the UK Medical Research Council. It is collaborating with Genomics England as part of the 100,000 Genomes Project.

Lead clinician for the NHS Scotland Genetics Consortium and lead clinical geneticist for the Scottish Genomes Partnership, Professor Zosia Miedzybrodzka of the University of Aberdeen, said: "NHS Scotland scientists and clinicians will be working over the next year to turn the complex DNA sequence data we have collected already into test results that can make a real difference to the lives of patients and their families."

Fiona Murphy, Director of the NHS National Services Division, said: "Innovation has driven huge changes in the NHS over the past 70 years with new technologies bringing benefits to all patients. Genomics will be central to future medical advances and it is fantastic to be part of the SGP leading a new wave of innovation in the NHS in Scotland."

Explore further: Gene study to shed light on how some people stay sharp in old age

Related Stories

Gene study to shed light on how some people stay sharp in old age

June 6, 2016
More than one thousand people have had their entire genetic make-up decoded as part of a long-term study to gain insight into why some people's brains age better than others.

Scotland launches world's first national atlas of palliative care

September 23, 2016
The first Scottish Atlas of Palliative Care has been by University of Glasgow academics at a major palliative care conference in Edinburgh.

'Unacceptable' cancer treatment waiting times condemned as Scottish targets missed again

March 30, 2017
Waiting times for cancer patients in Scotland have been described as 'unacceptable' after new figures show that a key target has been missed for the fourth year in a row.

Recommended for you

Gene mutation found to cause macrocephaly and intellectual deficits

November 13, 2018
The absence of one copy of a single gene in the brain causes a rare, as-yet-unnamed neurological disorder, according to new research that builds on decades of work by a University at Buffalo biochemist and his colleagues.

Mutations, CRISPR, and the biology behind movement disorders

November 12, 2018
Scientists at the RIKEN Center for Brain Science (CBS) in Japan have discovered how mutations related to a group of movement disorders produce their effects. Published in Proceedings of the National Academy of Sciences, the ...

Decrease in specific gene 'silencing' molecules linked with pediatric brain tumors

November 12, 2018
Experimenting with lab-grown brain cancer cells, Johns Hopkins Medicine researchers have added to evidence that a shortage of specific tiny molecules that silence certain genes is linked to the development and growth of pediatric ...

Recessive genes explain only small fraction of undiagnosed developmental disorders

November 8, 2018
The Deciphering Developmental Disorders study has discovered that only a small fraction of rare, undiagnosed developmental disorders in the British Isles are caused by recessive genes. The study by researchers from the Wellcome ...

A look at how colds and chronic disease affect DNA expression

November 8, 2018
We're all born with a DNA sequence that encodes (in the form of genes) the very traits that make us, us—eye color, height, and even personality. We think of those genes as unchanging, but in reality, the way they are expressed, ...

Mutant protein tackles DNA guardian to promote cancer development

November 7, 2018
Melbourne scientists have discovered how tumour development is driven by mutations in the most important gene in preventing cancer, p53.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.